Regen BioPharma Inc (RGBP)

[archilles]

RGBP is a different beast from ENZ$

1) It has a patent on mRMA cellular cancer vaccine,

2) It has one patent on "Methods and means of generating IL-17 associated antitumor effector cells by inhibition of NR2F6 inhibition"

3)It has a patent on "STIMULATION OF T REGULATORY CELLS BY CANNABIDIOL AS A MEANS OF TREATING ARTHRITIS AND AUTOIMMUNITY"

4) It has another patent on "SMALL MOLECULE MODULATORS OF NR2F6 ACTIVITY"

These patents belong to RGBP. If any biopharmaceutical companies want to do anything closely related to mRNA vaccines or the other three patents, they would have to pay lots of money for licensing if agreed by Dr. Koos. It may be cheaper for a pharma to buy out RGBP in the billions of dollar to own all these patents.

Buy-out PPS depends on which pharma will buy and how much and other criteria. The current filing when it arrives will open the flood gate for even bigger opportunities including merger, buyout, licensing etc..

I would not want to put a number as to how high PPS (intra-day) will go. Anyone is entitled to his or her prediction, but no one will know for sure what the PPS will end up at until the end of the trading day .

$RGBP

$RGPB